產(chǎn)品詳情
簡單介紹：
Anti-BBS2抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-BBS2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-BBS2
Cat. Number:
Anti-BBS2抗體KL-11506R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Bardet-Biedl syndrome Anti-BBS2抗體(BBS) is a pleiotropic genetic disorder characterized by obesity, photoreceptor degeneration, polydactyly, hypogenitalism, renal abnormalities, and developmental delay. Other associated clinical findings in BBS patients include diabetes, hypertension, and congenital heart defects. BBS is a heterogeneous disorder that maps to eight genetic loci and encodes eight proteins, BBS1-BBS8. Five BBS genes encode basal body or cilia proteins, suggesting that BBS is a ciliary dysfunction disorder. BBS2 is a 721-amino acid protein that is evolutionarily conserved and is expressed in a broad range of tissues including: brain, kidney, adrenal gland, and thyroid gland. Loss of BBS2 may be involved in defects in social interactions as well as infertility. BBS2 retinopathy involves normal retina development followed by apoptotic death of photoreceptors, the primary ciliated cells of the retina.Anti-BBS2抗體
Also known as:
Bardet Biedl syndrome 2; Bardet Biedl syndrome 2 protein; BBS; MGC20703; BBS2_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.Anti-BBS2抗體
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BBS2.
●
Predicted Molecular Weight: 80kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be Anti-BBS2抗體determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be Anti-BBS2抗體determined by the end user.
kl439Mu01 蛋白激酶Cε(PKCε)多克隆抗體 Polyclonal Antibody to Protein Kinase C Epsilon (PKCe)
kl442Hu01 阻抑素(PHB)多克隆抗體 Polyclonal Antibody to Prohibitin (PHB)
kl442Mu01 阻抑素(PHB)多克隆抗體 Polyclonal Antibody to Prohibitin (PHB)
kl442Ra01 阻抑素(PHB)多克隆抗體 Polyclonal Antibody to Prohibitin (PHB)
kl444Hu01 橋粒芯糖蛋白3(DSG3)多克隆抗體 Polyclonal Antibody to Desmoglein 3 (DSG3)
kl446Hu01 抑制素βC(INHβC)多克隆抗體 Polyclonal Antibody to Inhibin Beta C (INHbC)
kl446Ra01 抑制素βC(INHβC)多克隆抗體 Polyclonal Antibody to Inhibin Beta C (INHbC)
kl449Hu01 胱天蛋白酶7(CASP7)多克隆抗體 Polyclonal Antibody to Caskle 7 (CASP7)
kl449Mu01 胱天蛋白酶7(CASP7)多克隆抗體 Polyclonal Antibody to Caskle 7 (CASP7)
kl449Ra01 胱天蛋白酶7(CASP7)多克隆抗體 Polyclonal Antibody to Caskle 7 (CASP7)
kl450Hu01 激肽釋放酶4(KLK4)多克隆抗體 Polyclonal Antibody to Kallikrein 4 (KLK4)
kl450Mu01 激肽釋放酶4(KLK4)多克隆抗體 Polyclonal Antibody to Kallikrein 4 (KLK4)
kl450Ra01 激肽釋放酶4(KLK4)多克隆抗體 Polyclonal Antibody to Kallikrein 4 (KLK4)
kl451Hu01 激肽釋放酶5(KLK5)多克隆抗體 Polyclonal Antibody to Kallikrein 5 (KLK5)
kl451Mu01 激肽釋放酶5(KLK5)多克隆抗體 Polyclonal Antibody to Kallikrein 5 (KLK5)
kl457Hu01 胱天蛋白酶14(CASP14)多克隆抗體 Polyclonal Antibody to Caskle 14 (CASP14)
kl457Mu01 胱天蛋白酶14(CASP14)多克隆抗體 Polyclonal Antibody to Caskle 14 (CASP14)
kl457Ra01 胱天蛋白酶14(CASP14)多克隆抗體 Polyclonal Antibody to Caskle 14 (CASP14)
kl464Hu01 鹽皮質(zhì)**受體(MR)多克隆抗體 Polyclonal Antibody to Mineralocorticoid Receptor (MR)
kl464Ra01 鹽皮質(zhì)**受體(MR)多克隆抗體 Polyclonal Antibody to Mineralocorticoid Receptor (MR)
